These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7337233)

  • 1. Fractionation of heparin using antithrombin III reversibly bound to concanavalin A-sepharose.
    Denton J; Lewis WE; Nieduszynski IA; Phelps CF
    Anal Biochem; 1981 Dec; 118(2):388-91. PubMed ID: 7337233
    [No Abstract]   [Full Text] [Related]  

  • 2. Affinity chromatography in the separation of human alpha 1-antitrypsin (alpha 1-AT) and antithrombin-III (AT-III).
    D'Souza S; Ananthakrishnan R
    Aust J Exp Biol Med Sci; 1979 Jun; 57(3):245-50. PubMed ID: 316999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved method for removal of antithrombin III from post-heparin plasma lipase fractions with a high recovery rate.
    Moriguchi EH; Tamachi H; Homma Y; Goto Y
    Tokai J Exp Clin Med; 1991 Mar; 16(1):33-41. PubMed ID: 1780907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of heparin on Sepharose CL-4B in the presence of high concentrations of ammonium sulphate.
    Uchiyama H; Fujimoto N; Sakurai K; Nagasawa K
    J Chromatogr; 1984 Mar; 287(1):55-66. PubMed ID: 6725457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of highly stable antithrombin-sepharose and utilization for the fractionation of heparin.
    Pixley R; Danishefsky I
    Thromb Res; 1982 Apr; 26(2):129-33. PubMed ID: 7112509
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparation of three types of heparin-sepharose and their binding activities to thrombin and antithrombin III.
    Funahashi M; Matsumoto I; Seno N
    Anal Biochem; 1982 Nov; 126(2):414-21. PubMed ID: 7158775
    [No Abstract]   [Full Text] [Related]  

  • 7. Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.
    Andrade-Gordon P; Strickland S
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1865-9. PubMed ID: 2106684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphotungstate as a useful eluent for antithrombin III purification by heparin-agarose affinity chromatography.
    Tajima Y; Shizuka R; Oshitani S; Amagai H
    Thromb Res; 1990 Mar; 57(5):697-704. PubMed ID: 2339364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methods.
    Thaler E; Schmer G
    Br J Haematol; 1975 Oct; 31(2):233-43. PubMed ID: 53066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin with two binding sites for antithrombin or platelet factor 4.
    Jordan RE; Favreau LV; Braswell EH; Rosenberg RD
    J Biol Chem; 1982 Jan; 257(1):400-6. PubMed ID: 7053378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel matrix for high performance affinity chromatography and its application in the purification of antithrombin III.
    Zhao R; Luo J; Shangguan D; Liu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):175-81. PubMed ID: 15664348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatan sulfate and heparin can be fractionated by affinity for heparin cofactor II.
    Griffith MJ; Marbet GA
    Biochem Biophys Res Commun; 1983 Apr; 112(2):663-70. PubMed ID: 6687802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation of human neutrophils by heparin.
    Lazarowski ER; Santomé JA; Behrens NH; Sanchez Avalos JC
    Thromb Res; 1986 Feb; 41(4):437-46. PubMed ID: 3961733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chromatography of thrombin and antithrombin III on biospecific silochromes].
    Lohins'ka ZV; Oryshchenko NV; Vus MM; Maherovskyĭ IuV; Haĭda HZ; Haĭda AV
    Ukr Biokhim Zh (1978); 1998; 70(3):63-8. PubMed ID: 9848182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin III Alger: a new homozygous AT III variant.
    Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
    Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III-binding capacity of heparin-sepharose as a function of activation temperature and duration.
    Winkelman L
    Thromb Res; 1983 Feb; 29(3):383-6. PubMed ID: 6845286
    [No Abstract]   [Full Text] [Related]  

  • 18. Physiological variant of antithrombin-III lacks carbohydrate sidechain at Asn 135.
    Brennan SO; George PM; Jordan RE
    FEBS Lett; 1987 Jul; 219(2):431-6. PubMed ID: 3609301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three novel high performance affinity chromatographic media for the separation of antithrombin III from human plasma.
    Zhao Y; Zhao R; Shangguan D; Xiong S; Liu G
    Biomed Chromatogr; 2001 Dec; 15(8):487-92. PubMed ID: 11748680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.